Latest News about REGN
Recent news which mentions REGN
From Motley Fool
Sanofi Raises 2024 Profit Outlook On Strong Q2 Earnings, Blockbuster Drug Dupixent Sees Strong Demand
July 25, 2024
From Benzinga
MAIA Biotechnology's Lung Cancer Drug Shows Promising Long-Term Benefits In Advanced Patients
July 23, 2024
From Benzinga
From Benzinga
Johnson & Johnson Prioritizes Sustainable Growth in M&A Amid Sector Diversification, Says Analyst
July 18, 2024
From Benzinga
3 Standout Stocks to Buy for the Next Bull Market
July 18, 2024
From InvestorPlace
Stocks to Buy: 7 Founder-Led Companies Set to Outperform
July 17, 2024
From InvestorPlace
Exploring The Competitive Space: Regeneron Pharmaceuticals Versus Industry Peers In Biotechnology
July 16, 2024
From Benzinga
From Benzinga
From Motley Fool
From InvestorPlace
3 No-Brainer Stocks to Buy in July
July 08, 2024
From Motley Fool
From InvestorPlace
The 3 Best Biotech Stocks to Buy in July 2024
July 05, 2024
From InvestorPlace
From InvestorPlace
From Benzinga
Europe Approves Sanofi/Regeneron's Dupixent for 'Smoker's Lungs' A Month After US FDA Asks For Data
July 03, 2024
From Benzinga
From Benzinga
First Inhaled COPD Therapy In Over 2 Decades - FDA Approves Verona Pharma's First Commercial Product
June 27, 2024
From Benzinga
3 Biotech Stocks That Could Make Your Grandchildren Rich
June 27, 2024
From InvestorPlace
Regeneron Pharmaceuticals' Approach To Improve Quality Of Weight Loss Has Merit: Goldman Sachs
June 24, 2024
From Benzinga
From Benzinga
Gilead Sciences Faces Wall Street Speculation About Obesity Drugs Despite Focus On Liver Treatments
June 21, 2024
From Benzinga
From InvestorPlace
From Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
|
|
|